Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Jacques Patard

Showing results (71-80 of 248) with videos related to

Pageof 25
Sort By:
Journal of Cancer Research and Clinical Oncology|February 11, 2012
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell linesBénédicte Martin, Julien Edeline, Jean-Jacques Patard, et al.
Annals of Surgical Oncology|November 12, 2014
Are urologists and radiologists equally effective in determining the RENAL Nephrometry score?Steeve Benadiba, Anne-Laure Verin, Geraldine Pignot, et al.
Urologic Oncology|September 2, 2014
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapyPierre Blanchard, Moudar Bakkour, Renaud De Crevoisier, et al.
Scandinavian Journal of Urology and Nephrology|December 19, 2002
Management of vascular access for hemodialysis after successful kidney transplantationJean-Jacques Patard, Karim Bensalah, Antoine Lucas, et al.
European Urology|December 6, 2011
Positive surgical margins after nephron-sparing surgeryMartin Marszalek, Marco Carini, Piotr Chlosta, et al.
European Urology|December 7, 2007
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinomaNaeem Bhojani, Claudio Jeldres, Jean-Jacques Patard, et al.
Cancer|July 20, 2007
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patientsPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
The Journal of Urology|July 24, 2012
Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenariansJulien Berger, Tarek Fardoun, Elena Brassart, et al.
Human Pathology|May 26, 2012
Description of 2 angiogenic phenotypes in clear cell renal cell carcinomaJulien Edeline, Stéphanie Mottier, Cécile Vigneau, et al.
European Urology|September 24, 2011
Lymph node dissection in renal cell carcinomaUmberto Capitanio, Frank Becker, Michael L Blute, et al.
Pageof 25

Showing results (71-80 of 248) with videos related to

Sort By:
Pageof 25
Journal of Cancer Research and Clinical Oncology|February 11, 2012
Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell linesBénédicte Martin, Julien Edeline, Jean-Jacques Patard, et al.
Annals of Surgical Oncology|November 12, 2014
Are urologists and radiologists equally effective in determining the RENAL Nephrometry score?Steeve Benadiba, Anne-Laure Verin, Geraldine Pignot, et al.
Urologic Oncology|September 2, 2014
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapyPierre Blanchard, Moudar Bakkour, Renaud De Crevoisier, et al.
Scandinavian Journal of Urology and Nephrology|December 19, 2002
Management of vascular access for hemodialysis after successful kidney transplantationJean-Jacques Patard, Karim Bensalah, Antoine Lucas, et al.
European Urology|December 6, 2011
Positive surgical margins after nephron-sparing surgeryMartin Marszalek, Marco Carini, Piotr Chlosta, et al.
European Urology|December 7, 2007
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinomaNaeem Bhojani, Claudio Jeldres, Jean-Jacques Patard, et al.
Cancer|July 20, 2007
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patientsPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
The Journal of Urology|July 24, 2012
Detailed analysis of morbidity following nephrectomy for renal cell carcinoma in octogenariansJulien Berger, Tarek Fardoun, Elena Brassart, et al.
Human Pathology|May 26, 2012
Description of 2 angiogenic phenotypes in clear cell renal cell carcinomaJulien Edeline, Stéphanie Mottier, Cécile Vigneau, et al.
European Urology|September 24, 2011
Lymph node dissection in renal cell carcinomaUmberto Capitanio, Frank Becker, Michael L Blute, et al.
Pageof 25